Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-574-9 | CAS number: 13845-36-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
See read-across justification report under Section 13 ‘Assessment Reports’.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
In accordance with REACH Annex XI, Section 1.5, of Regulation (EC) No. 1907/2006 (REACH) the standard testing regime may be adapted in cases where a grouping or read-across approach has been applied.
The similarities may be based on:
(1) a common functional group
(2) the common precursors and/or the likelihood of common breakdown products via physical or biological processes, which result in structurally similar chemicals; or
(3) a constant pattern in the changing of the potency of the properties across the category
1. Both substances are inorganic salts of a monovalent cation from Group 1A of the periodic table, and triphosphoric acid. Thus, they share the Na+ or K+ cation and P3O105- anion.
2. Both the Na+ and the K+ cation have a similar biological function and therefore triphosphate salts of these types are not considered to differ in their systemic toxicity profile; differences arise in their local effects profile due to the increasing or decreasing acidity/alkalinity and buffering capacities of the substances. This has been shown not to have an effect on systemic toxicity.
3. In addition, both salts have been shown to be of similar low toxicity in acute oral studies and therefore comparisons can be drawn to allow read-across for the acute inhalation endpoint
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
See read-across justification report under Section 13 ‘Assessment Reports’.
3. ANALOGUE APPROACH JUSTIFICATION
See read-across justification report under Section 13 ‘Assessment Reports’.
4. DATA MATRIX
See read-across justification report under Section 13 ‘Assessment Reports’.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Pentasodium triphosphate
- EC Number:
- 231-838-7
- EC Name:
- Pentasodium triphosphate
- Cas Number:
- 7758-29-4
- Molecular formula:
- Na5P3O10 H5-xP3O10Nax (where x is approximately 5) 6H2O.Na5P3O10
- IUPAC Name:
- Pentasodium triphosphate
- Details on test material:
- - Name of test material (as cited in study report): Sodium tripolyphosphate
- Substance type: White powder
- Purity: >90%
- Lot/batch No.: B5885327C
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Limited, Kent, UK
- Weight at study initiation: ~ 200 g
- Housing: Cages were made of polypropylene (size 38 cm x 56 cm x 18 cm height) and had detachable wire mesh tops and floors
- Diet: Free access to a measured excess amount of food (Labsure LAD 1)
- Water: Free access to water
- Acclimation period: At least 5 days prior to exposure
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Max (23) Min (19)
- Humidity (%): 63
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- not specified
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: A Wright dust generator
- Exposure chamber volume: 120 L
- Method of holding animals in test chamber: Rats were held in cages of stainless steel mesh partitioned to provide 10 individual animal compartments
- Method of conditioning air: The test atmosphere produced by the generator was passed through a glass elutriation column to reduce, by sedimentation the amount of non-respirable particulate.
- Method of particle size determination: Anderson mini-sampler
- Temperature in air chamber: Mean air temperature: 23.2°C(control) 22.6 °C (test).
- Relative humidity in air chamber: Mean relative humidity: 39% (control) 41% (test)
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0.39 mg/L (highest attainable concentrations)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Weighed daily until the end of the observation period
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, lung weights
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 0.39 mg/L air
- Exp. duration:
- 4 h
- Mortality:
- There were no deaths.
- Clinical signs:
- other: During exposure: signs consistent with exposure to an irritant dust. Partial closing of the eye, exaggerated respiratory movements, restless behaviour and excessive grooming were seen in all exposed rats. During observation period: There were no clinical
- Body weight:
- Small losses in body weight or a decrease in the rate of body weight gain were observed for a proportion of male rats on the day following exposure. The losses in the male rats were statistically significant 9P<0.05)
- Gross pathology:
- The lung weight to body weight ratio for all rats was within normal limits. Grey areas were seen ion the lungs of 1 male rat exposed to the test substance. There were no abnormalities in any other rats.
- Other findings:
- Food and water consumption: Food consumption was reduced for 1 day in male rats and slightly reduced for 1 day in female rats following exposure. Water consumption was slightly reduced for 1 day in male rats following exposure.
Any other information on results incl. tables
Table 1: Concentrations of sodium tripolyphosphate (Gravimetric determination):
Sample |
Time |
Amount in air (mg/L) |
2.1 |
0 h:30 m |
0.53 |
2.2 |
1h:00m |
0.50 |
2.3 |
2h:00m |
0.35 |
2.4 |
3h:00m |
0.29 |
2.5 |
3h:50m |
0.27 |
Mean |
0.39 |
|
SD |
0.120 |
The mean concentration of sodium tripolyphosphate was 0.39 mg/L and was the highest attainable. The concentration achieved indictaes that the test susbstance contains only a low proportion of small particles.
Table 2: Particle size distribution of sodium tripolyphosphate:
Sample |
Time |
Stage |
Particle size range (µm) |
Amount collected (mg) |
% of total |
% respirable |
PSD 1 |
1h:30m |
1 |
>5.5 |
1.00 |
64.9 |
35.1 |
2 |
3.5-5.5 |
0.16 |
10.4 |
|||
3 |
2.0-3.5 |
0.20 |
13.0 |
|||
4 |
0.3-2.0 |
0.10 |
6.5 |
|||
Filter |
0.3 |
0.08 |
5.2 |
|||
Totals |
1.54 |
100.0 |
||||
PSD 2 |
3 h:30m |
1 |
>5.5 |
0.64 |
81.0 |
19.0 |
2 |
3.5-5.5 |
0.02 |
2.5 |
|||
3 |
2.0-3.5 |
0.09 |
11.4 |
|||
4 |
0.3-2.0 |
0.04 |
5.1 |
|||
Filter |
0.3 |
0.00 |
0.0 |
|||
Totals |
0.79 |
100.0 |
The results in table 2 show that on average 27% of the dust collected was 5.5 µm or less in aerodynamic diameter and therefore of respirable size.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, the test material caused no mortality when administered for 4 h to Wistar rats at a mean, maximum attainable concentration of 0.39 mg/L air. Based on this, the LC50 for the test material is considered to be greater than 0.39 mg/L. This study is considered to be acceptable and to adequately satisfy both the guideline requirement and the regulatory requirement for this endpoint.
As the study was conducted up to the maximum attainable concentration and in accordance with Regulation (EC) No. 1272/2008 (EU CLP) pentasodium triphosphate is not considered to be classified.
Read across from pentasodium triphosphate to pentapotassium triphosphate is justified on the following basis:
Both substances are ionic inorganic compounds containing a triphosphate anion and a group 1 alkali metal cation. Both the Na+ and the K+ cation have a similar biological function and therefore triphosphate salts of these types are not considered to differ in their systemic toxicity profile; differences arise in their local effects profile due to the increasing or decreasing acidity/alkalinity and buffering capacities of the substances. This has been shown not to have an effect on systemic toxicity.
In addition, both salts have been shown to be of similar low toxicity in acute oral studies and therefore comparisons can be drawn to allow read-across for the acute inhalation endpoint.
This study is therefore deemed reliable for classification and labeling according to Regulation (EC) No 1272/2008 (EU CLP) and further testing is considered to be scientifically unjustified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.